PharmaResources provides process route selection services based on different needs, including generic drug innovative process route selection, innovative drug route development, etc. Based on product development requirements, we determine QTPP, CQA, key process parameters through DOE experiments, engineering batch manufacturing, and provide process validation services for engineering batch production and compliance with NMPA and FDA.
-
Starting material-based synthetic route selection
-
Cost-based synthetic route selection
-
Quality control-based route selection
-
Process patent breakthrough/innovative process route selection
-
Cost-based route selection
-
Generic drug process route selection
Highly active drug process selection and development
-
Meeting the needs of toxicology batch and clinical batch manufacturing and commercial manufacturing
-
DOE experiments for process characterization to determine operating parameter ranges
-
Process development based on Quality Risk Assessment (QRA), to determine critical process steps/parameters CPP/PAR/NOR
-
Process development for pilot test, process transfer, and process validation